SINERDOL ISO 300mcg / 150mcg capsules medication leaflet

J04AM02 • rifampicin + isoniazid • Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Combinations of drugs for treatment of tuberculosis

The combination of rifampicin and isoniazid is used for the treatment and prevention of tuberculosis (TB). Rifampicin works by inhibiting bacterial RNA synthesis, while isoniazid interferes with the synthesis of the cell wall of Mycobacterium tuberculosis.

The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen to prevent the development of bacterial resistance.

Patients should be aware of potential side effects, such as nausea, fatigue, or liver-related symptoms like jaundice. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, fatigue, and liver-related symptoms. In rare cases, severe reactions such as hepatotoxicity or allergic reactions may occur. Patients should be informed of these risks before starting treatment.